Literature DB >> 18481023

Suppression of inducible nitric oxide synthase and cyclooxygenase-2 expression by tussilagone from Farfarae flos in BV-2 microglial cells.

Hyo Jin Lim1, Hyun-Sun Lee, Jae-Ha Ryu.   

Abstract

Activated microglia produce diverse neurotoxic factors such as nitric oxide (NO) and prostaglandin E(2) (PGE(2)) that may cause neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. From the EtOAc soluble fraction of Farfarae flos (Tussilago farfara), we purified tussilagone as a bioactive compound by monitoring the inhibitory potential of NO production in activated microglia through the purification procedures. Tussilagone showed dose-dependent inhibition of NO and PGE(2) production in LPS-activated microglia with IC(50) values of 8.67 microM and 14.1 microM, respectively. It suppressed the expression of protein and mRNA of inducible nitric oxide synthase and cyclooxygenase-2 through the inhibition of 1-kappaBalpha degradation and nuclear translocation of p65 subunit of NF-kappaB. Therefore tussilagone from Farfarae flos may have therapeutic potential in the treatment of neuro-inflammatory diseases through the inhibition of overproduction of NO and PGE(2).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481023     DOI: 10.1007/s12272-001-1207-4

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  7 in total

1.  Effects of Flower Buds Extract of Tussilago farfara on Focal Cerebral Ischemia in Rats and Inflammatory Response in BV2 Microglia.

Authors:  Ji Hye Hwang; Vinoth R Kumar; Seok Yong Kang; Hyo Won Jung; Yong-Ki Park
Journal:  Chin J Integr Med       Date:  2018-08-08       Impact factor: 1.978

2.  A Comparative Analysis of the Anatomy, Phenolic Profile, and Antioxidant Capacity of Tussilago farfara L. Vegetative Organs.

Authors:  Viviane Beatrice Bota; Andreea-Adriana Neamtu; Neli-Kinga Olah; Elisabeta Chișe; Ramona Flavia Burtescu; Flavia Roxana Pripon Furtuna; Alexandru-Sabin Nicula; Carmen Neamtu; Adrian-Marius Maghiar; Lăcrămioara-Carmen Ivănescu; Maria-Magdalena Zamfirache; Endre Mathe; Violeta Turcuș
Journal:  Plants (Basel)       Date:  2022-06-23

3.  Tussilagone Inhibits the Inflammatory Response and Improves Survival in CLP-Induced Septic Mice.

Authors:  Yun Kyu Kim; Myeong Gu Yeo; Bo Kang Oh; Ha Yeong Kim; Hun Ji Yang; Seung-Sik Cho; Minchan Gil; Kyung Jin Lee
Journal:  Int J Mol Sci       Date:  2017-12-18       Impact factor: 5.923

4.  Tussilagone suppressed the production and gene expression of MUC5AC mucin via regulating nuclear factor-kappa B signaling pathway in airway epithelial cells.

Authors:  Byung-Soo Choi; Yu-Jin Kim; Yong Pill Yoon; Hyun Jae Lee; Choong Jae Lee
Journal:  Korean J Physiol Pharmacol       Date:  2018-10-25       Impact factor: 2.016

5.  Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways.

Authors:  Xuantao Hu; Ziqing Yin; Xia Chen; Guangyao Jiang; Daishui Yang; Ziqin Cao; Shuai Li; Zicheng Liu; Dan Peng; Pengcheng Dou
Journal:  Front Pharmacol       Date:  2020-04-03       Impact factor: 5.810

Review 6.  A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot).

Authors:  Shujuan Chen; Lin Dong; Hongfeng Quan; Xirong Zhou; Jiahua Ma; Wenxin Xia; Hao Zhou; Xueyan Fu
Journal:  J Ethnopharmacol       Date:  2020-10-16       Impact factor: 4.360

7.  Tussilagone Reduces Tumorigenesis by Diminishing Inflammation in Experimental Colitis-Associated Colon Cancer.

Authors:  Sang-Hyeon Nam; Jin-Kyung Kim
Journal:  Biomedicines       Date:  2020-04-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.